HEART DISEASE IS THE LEADING CAUSE OF DEATH FOR WOMEN IN THE UNITED STATES, RESPONSIBLE for 1 in every 4 women's deaths. Despite increases in awareness over the past decade, only 54% of women recognize that heart disease is their number 1 killer. Almost two-thirds (64%) of women who die suddenly of coronary heart disease have no previous symptoms. By race, heart disease is also the leading cause of death equally for African-American and white women in the United States. Among Hispanic women, heart disease and cancer cause roughly the same number of deaths each year. For American-Indian or Alaska Native and Asian or Pacific Islander women, heart disease is second only to cancer. Women presenting with suspected or with known coronary artery disease are generally older and have higher incidences of diabetes, hypertension, and often a clustering of risk factors. Women also present with more anginal-equivalent or atypical symptoms (A) NHLBI-WISE data: Symptoms, even atypical, are not benign, in women. All suspected IHD symptoms, even atypical chest pain are associated with 5-year CVD events compared with the lower risk noted for asymptomatic women (2). This higher risk is also noted for women with mild but nonobstructive coronary artery disease (CAD). Reprinted with permission from Gulati et al. (Arch Intern Med 2009;169:843-50). (B) The CONFIRM International Multicenter Registry. Obstructive CAD prevalence in women. Rates of obstructive CAD are lower than historical estimates. Across the patterns of symptom presentation, women have lower rates of obstructive CAD, which is consistently <20% across the varying symptom presentations. Reprinted with permission from Cheng et al. (Circulation 2011;124:2423-32). CP ¼ chest pain; CV ¼ cardiovascular.
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(A) NHLBI-WISE data: Symptoms, even atypical, are not benign, in women. All suspected IHD symptoms, even atypical chest pain are associated with 5-year CVD events compared with the lower risk noted for asymptomatic women (2). This higher risk is also noted for women with mild but nonobstructive coronary artery disease (CAD). Reprinted with permission from Gulati et al. (Arch Intern Med 2009; 169:843-50) . (B) The CONFIRM International Multicenter Registry. Obstructive CAD prevalence in women. Rates of obstructive CAD are lower than historical estimates. Across the patterns of symptom presentation, women have lower rates of obstructive CAD, which is consistently <20% across the varying symptom presentations. Reprinted with permission from Cheng et al. (Circulation 2011; 124:2423-32) . CP ¼ chest pain; CV ¼ cardiovascular.
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R E F E R E N C E S
There is a substantial evidence that women are undertreated and underdiagnosed. With regard to treatment, reports have noted that women receive less aspirin; beta blocker, statin, and antiarrhythmic agents; cardiac catheterization, stress tests, percutaneous coronary intervention, coronary bypass surgery, and are counseled less about nutrition, exercise, and weight control. Given the vast differences in the intensity of diagnosis and treatment for women compared with men, these differences contribute to the worse clinical outcomes of women. Abbreviation as in Figure 1 . Adapted from Bowling et al.
(Heart 2001;85:680-6). 
